Hot flash.
Conditions
Interventions
Intervention 1: Intervention group: received tablet Soyagol ( 50 mg isoflavone) ,Goldaru Pharmaceutical Company , one before lunch and one before dinner, for 12 weeks. Intervention 2: Control group
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
40 Years to No maximum
Inclusion criteria
Inclusion criteria: over 40 years of age body mass index in range of 20-35Kg/m2 With hot flushes
Exclusion criteria
Exclusion criteria: Women with previous history of cancer,diabetes mellitus or renal, hepatic, and heart failure or abnormal uterine bleeding, mioma, ovarian cyst, Poly Cystic Ovarian syndrome(PCOS), endometriosis hormone therapy during the last three months, Patients with disability or known history of drug or alcohol consumption Cigarette smoking and caffeine consumption
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hot flashing were categorized in mild, moderate and severe. Timepoint: before and 6 and 12 months after intervention. Method of measurement: questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Endometrial thickness. Timepoint: Before and 6, 12 months after intervention. Method of measurement: Endometrial thickness was evaluated using ulthrasonography.;Breast changes. Timepoint: Before and 6, 12 months after intervention. Method of measurement: Breast sonography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSadaf Alipour
Tehran University of Medical Sciences
Outcome results
None listed